Clinical Trial

A Study of Takhzyro in Teenagers and Adults With Hereditary Angioedema (HAE) in South Korea

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Takhzyro is an approved treatment for hereditary angioedema (HAE) in South Korea. HAE is a rare condition which causes sudden swelling under the skin and inside the body, like in the belly, throat, or genitals. The main aim of this study is to check how safe Takhzyro is in teenagers and adults with HAE in everyday medical care in South Korea. Another aim is to see how well Takhzyro works in everyday medical care. The treatment of participants and any check-ups will be determined by the treating doctors according to their normal practice. Participants may visit the study clinic several times during the study.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2026-02-25; most recent amendment 2026-06-17.
Trial Details
NCT Number NCT07445087
Lead Sponsor Takeda
Conditions Hereditary Angioedema (HAE)
Enrollment 35 participants
Start Date 2026-10-01
Primary Completion 2032-02-29 (estimated)
Study Completion 2032-02-29 (estimated)
Updated on ClinicalTrials.gov 2026-06-18